Cargando…
Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single‐center retrospective analysis
Neuroendocrine tumors (NETs) are more commonly slow‐growing, therefore patients often receive chronic systemic therapies for tumor growth control and preservation of quality of life. Metronomic chemotherapy (mCT) is in line with this goal as it leads to stabilization of tumor growth over time withou...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786253/ https://www.ncbi.nlm.nih.gov/pubmed/36306196 http://dx.doi.org/10.1111/jne.13189 |